John Ewald is a trial lawyer with a particular emphasis on mass torts and product liability.
John plays a critical role in Orrick’s ongoing representation of Johnson & Johnson as national coordinating counsel in lawsuits alleging that the company's talcum powder products causes mesothelioma and ovarian cancer. John serves as trial counsel in those cases and also is responsible for developing and coordinating the company's national scientific and medical defense.
In October 2019, John
served as lead trial counsel for Johnson & Johnson in a suit seeking at
least $25 million that alleged the company’s talc products caused the
plaintiff’s mesothelioma. After a
five-week trial, a Los Angeles state court jury rejected all of plaintiffs’ claims and
returned a complete defense verdict for Johnson & Johnson.
was also trial counsel in November 2018 for Johnson & Johnson in South Carolina state court where a jury reached a second mistrial in a case that sought $63 million in
compensatory damages against the company for allegedly causing the plaintiff's fatal mesothelioma. Law360 cited
the case as one of the “Top Product Liability cases of 2018.”
John was recognized in The Legal 500 United States for Product Liability, Mass Tort and Class Action: Toxic Tort - Defense in 2018–2019. John was also recognized by New York Super Lawyers as a “Rising Star” from 2013 to 2019 for class action and mass torts.
John actively participates in Orrick's pro bono program. He received the 2010 Orrick Pro Bono Award for significant pro bono contributions, including his representation of a Guantanamo Bay detainee before the United States Court of Appeals for the District of Columbia. As counsel of record, John drafted the briefs and argued the case in the D.C. Circuit. Awad v. Obama, 608 F.3d 1 (D.C. Cir. 2010).
Before joining Orrick as an associate, he was a summer associate in the New York office in 2002.